Breast cancer resistance protein (BCRP/ABCG2) does not confer resistance to gemtuzumab ozogamicin and calicheamicin-gamma1 in acute myeloid leukemia cells.
Walter
R B
RB
Raden
B W
BW
Thompson
J
J
Flowers
D A
DA
Kiem
H-P
HP
Bernstein
I D
ID
Linenberger
M L
ML
D000070997:ATP Binding Cassette Transporter, Subfamily G, Member 2; D018528:ATP-Binding Cassette Transporters / Q000378:metabolism*; D000208:Acute Disease; D000617:Aminoglycosides / Q000627:therapeutic use*; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D018432:Drug Resistance, Multiple; D019008:Drug Resistance, Neoplasm; D053281:Enediynes; D000079982:Gemtuzumab; D006801:Humans; D000922:Immunotoxins / Q000627:therapeutic use*; D007951:Leukemia, Myeloid / Q000188:drug therapy*; D008727:Methotrexate; D009363:Neoplasm Proteins / Q000378:metabolism*; D014407:Tumor Cells, Cultured
C116614:ABCG2 protein, human; D000070997:ATP Binding Cassette Transporter, Subfamily G, Member 2; D018528:ATP-Binding Cassette Transporters; D000617:Aminoglycosides; D000903:Antibiotics, Antineoplastic; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D053281:Enediynes; D000922:Immunotoxins; D009363:Neoplasm Proteins; C055955:calicheamicin gamma(1)I; D000079982:Gemtuzumab; D008727:Methotrexate